A shocking new report has shed light on the final moments of Liam Payne, the former One Direction star who tragically passed away in October after falling from a hotel balcony in Buenos Aires, Argentina. According to the latest findings from the National Criminal and Correctional Prosecutor’s Office No. 14, Liam had a blood alcohol concentration (BAC) of 0.27% at the time of his death, which is significantly high and could explain the confusion and disorientation he experienced before the fatal fall.
In addition to the alcohol, Payne’s system also contained traces of cocaine metabolites, including methylecgonine, benzoylecgomine, and cocaethylene, as well as sertraline, a prescription antidepressant. The toxicology results, which came from extensive testing of his urine, blood, and vitreous humour, confirmed that Liam was not fully conscious at the time of his tragic fall.
Further investigation revealed that Braian Paiz, who had previously denied supplying Payne with drugs, was indeed involved in the sale of narcotics to the singer. Security footage from the hotel and text message exchanges between Payne and Paiz confirmed that drugs were exchanged for money, despite Paiz’s earlier claims that the substances were a “gift.”
The prosecutor’s office also confirmed that charges against several individuals linked to Liam’s death have been dropped. His friend Roger Nores, along with two hotel employees, Gilda Martin and Esteban Grassi, were cleared of manslaughter charges, which could have resulted in prison sentences. However, Paiz and another suspect, Ezequiel Pereyra, remain in custody as they await trial, facing potential sentences of 4 to 14 years if convicted.
Liam Payne’s death has left fans and loved ones devastated, but these findings provide a clearer picture of the circumstances surrounding his tragic passing. As investigations continue, our thoughts remain with Liam’s family and friends during this difficult time.
For those struggling with substance abuse, help is available through the SAMHSA helpline at 1-800-662-HELP.
Read more:
